Ligand · YG1
YG1 · N-{(11S)-2-[2-(5-hydroxypent-1-yn-1-yl)phenyl]-4H,10H-pyrazolo[5,1-c][1,4]benzoxazepin-7-yl}acetamide
YG1, N-{(11S)-2-[2-(5-hydroxypent-1-yn-1-yl)phenyl]-4H,10H-pyrazolo[5,1-c][1,4]benzoxazepin-7-yl}acetamide (C24 H23 N3 O3, 401.5 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its…
- Component
- YG1
- Formula
- C24 H23 N3 O3
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
YG1 in 2 structures; the first of them:
- 7LW1 · Human phosphofructokinase-1 liver type bound to activator NA-11 · YG1 A801 · binds MET174, ASP179, LEU182, TYR214, VAL218, PHE308, ILE311, LYS315 and 14 more
- 7LW1 · Human phosphofructokinase-1 liver type bound to activator na-11 · YG1 A801 · binds MET174, ASP179, LEU182, TYR214, PHE308, ILE311, LYS315, ASN341 and 9 more
Residues it binds most
PHE 8, LEU 8, ASN 8, ASP 8, TYR 8, VAL 8, ILE 8, LYS 8, MET 8, SER 8 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.